Interestingly, inhibiting RRM2 in hepatocellular carcinoma cells using celastrol has been shown to induce ferroptosis and suppress cell proliferation, migration, and invasion (Zhang et al., 2024). This evidence concerns the gene RRM2 and hepatocellular carcinoma.